Andmed seisuga: 22.11.2024 13:53 (GMT+2)
AS VIISNURK
INCOME STATEMENT
01.01-31.12.98
(EEK)
consolidated, audited
Group Group Parent Parent
1998 1997 1998 1997
NET SALES 201,619,366 200,611,652 200,033,775 200,611,652
Cost of sales (appendix 19) 154,028,702 148,120,716 151,663,928 148,120,716
Gross profit 47,590,664 52,490,936 48,369,847 52,490,936
Marketing expenses (appendix 20) 12,549,981 11,954,526 12,547,081 11,954,526
Administrative expenses (appendix 21) 10,415,032 11,479,801 10,202,275 11,479,801
Other commercial revenues (appendix 22) 1,152,308 290,977 1,144,488 290,977
Other commercial expenses (appendix 23) 2,356,879 4,091,463 2,161,726 4,091,463
Commercial profit 23,421,080 25,256,123 24,603,253 25,256,123
Financial revenues (appendix 24) 299,028 584,302 298,454 584,302
Financial expenses (appendix 25) 5,085,588 6,677,059 5,068,391 6,677,059
Operating profit 18,634,520 19,163,366 19,833,316 19,163,366
Potential income tax (appendix 26) 345,963 559,705 345,963 559,705
Income tax (appendix 26) 1,290,550 4,553,994 1,290,550 4,553,994
Profit for the financial year 16,998,007 14,049,667 18,196,803 14,049,667
Minority interest 591,006
Net profit for the group 17,589,013
Earnings per share 3.93 3.37
Diluted earnings per share 3.74 3.22